The basal cells in epithelium of the erythematous form of oral lichen display hyperproliferation compared with normal oral mucosa. In this study we examined whether this is associated with disrupted production, activation, or signal transduction of the epithelial growth inhibitor transforming growth factor (TGF) b1. In situ immunostaining showed that most epithelial cells in normal oral mucosa had nuclear and cytoplasmic Smad4 and phosphorylated Smad2/3, but expressed little or no Smad7. Expression of latency-associated peptide TGF-b1, latent TGF-b binding protein 1, TGF-b type I receptor, and TGF-b type II receptor was readily seen, but only very little TGF-b1 was activated. In erythematous oral lichen, basal and lower spinous epithelial layers showed staining for latency-associated peptide TGF-b1, TGF-b type I receptor, and TGF-b type II receptor. A band with scanty staining for these molecules, but with marked staining for active TGF-b1, was seen in the upper spinous and granular layers. Numbers of epithelial cell nuclei with Smad4 and phosphorylated Smad2/3 staining were signi¢cantly reduced in erythematous oral lichen compared with normal oral mucosa. Basal and suprabasal cell layers in erythematous oral lichen showed strong cytoplasmic Smad7 protein staining, but in spinous and granular layers Smad7 was localized to the cell membrane. In situ hybridization showed strong Smad7 mRNA expression in almost all basal keratinocytes in erythematous oral lichen; by contrast, no or occasionally very weak Smad7 mRNA expression was seen in these cells in normal oral mucosa. The observations indicate that inhibition of the TGF-b/Smad pathway may account for the hyperproliferation of keratinocytes in erythematous oral lichen. Key words: epithelial proliferation/ keratinocytes/oral mucosa. J Invest Dermatol 121: 00^00, 2003 O ral lichen (OL), which includes oral lichenoid reactions and oral lichen planus (OLP), is a common oral disease a¡ecting about 2% of the populations examined (Axell and Rundquist, 1987; Salonen et al, 1990) . Oral lichenoid reactions are de¢ned as adverse reactions to dental materials, whereas changes with unknown etiology are termed OLP (Bolewska et al, 1990) . Histologically, oral lichenoid reactions and OLP are indistinguishable from each other (Bolewska and Reibel, 1989) . The lesions are characterized by a typical band-like mononuclear in£ammatory in¢ltrate in the connective tissue, dominated by T lymphocytes (Hedberg et al, 1986) . Pathologic changes in the epithelium include hyperorthokeratosis or parakeratosis, acanthosis, atrophy, and liquefaction degeneration of basal cells (Andreasen, 1968; Kramer et al, 1978) . Clinically, OL shows white papular, reticular, erythematous, plaque, and ulcerative forms (Andreasen, 1968; Kramer et al, 1978) . Erythematous OL (ERY OL) is one of the common forms of the disease and is often associated with oral discomfort in the a¡ected persons (Andreasen, 1968) .
The basal cells in epithelium of the erythematous form of oral lichen display hyperproliferation compared with normal oral mucosa. In this study we examined whether this is associated with disrupted production, activation, or signal transduction of the epithelial growth inhibitor transforming growth factor (TGF) b1. In situ immunostaining showed that most epithelial cells in normal oral mucosa had nuclear and cytoplasmic Smad4 and phosphorylated Smad2/3, but expressed little or no Smad7. Expression of latency-associated peptide TGF-b1, latent TGF-b binding protein 1, TGF-b type I receptor, and TGF-b type II receptor was readily seen, but only very little TGF-b1 was activated. In erythematous oral lichen, basal and lower spinous epithelial layers showed staining for latency-associated peptide TGF-b1, TGF-b type I receptor, and TGF-b type II receptor. A band with scanty staining for these molecules, but with marked staining for active TGF-b1, was seen in the upper spinous and granular layers. Numbers of epithelial cell nuclei with Smad4 and phosphorylated Smad2/3 staining were signi¢cantly reduced in erythematous oral lichen compared with normal oral mucosa. Basal and suprabasal cell layers in erythematous oral lichen showed strong cytoplasmic Smad7 protein staining, but in spinous and granular layers Smad7 was localized to the cell membrane. In situ hybridization showed strong Smad7 mRNA expression in almost all basal keratinocytes in erythematous oral lichen; by contrast, no or occasionally very weak Smad7 mRNA expression was seen in these cells in normal oral mucosa. The observations indicate that inhibition of the TGF-b/Smad pathway may account for the hyperproliferation of keratinocytes in erythematous oral lichen. Key words: epithelial proliferation/ keratinocytes/oral mucosa. J Invest Dermatol 121: 00^00, 2003 O ral lichen (OL), which includes oral lichenoid reactions and oral lichen planus (OLP), is a common oral disease a¡ecting about 2% of the populations examined (Axell and Rundquist, 1987; Salonen et al, 1990) . Oral lichenoid reactions are de¢ned as adverse reactions to dental materials, whereas changes with unknown etiology are termed OLP (Bolewska et al, 1990) . Histologically, oral lichenoid reactions and OLP are indistinguishable from each other (Bolewska and Reibel, 1989) . The lesions are characterized by a typical band-like mononuclear in£ammatory in¢ltrate in the connective tissue, dominated by T lymphocytes (Hedberg et al, 1986) . Pathologic changes in the epithelium include hyperorthokeratosis or parakeratosis, acanthosis, atrophy, and liquefaction degeneration of basal cells (Andreasen, 1968; Kramer et al, 1978) . Clinically, OL shows white papular, reticular, erythematous, plaque, and ulcerative forms (Andreasen, 1968; Kramer et al, 1978) . Erythematous OL (ERY OL) is one of the common forms of the disease and is often associated with oral discomfort in the a¡ected persons (Andreasen, 1968) .
In order to maintain the strati¢ed epithelium's normal anatomy and thereby its functions, there is a ¢ne-tuned balance between the continuous proliferation of basal keratinocytes and maturation and cell death of terminally di¡erentiating keratinocytes (Gandarillas, 2000) . Epithelial proliferation and di¡erentiation are regulated by an intricate signaling network of di¡erent peptides (cytokines/growth factors) produced by keratinocytes themselves, stromal cells, and in¢ltrating in£ammatory cells and their respective receptors (Dotto, 1999; Freedberg et al, 2001 ). Transforming growth factor b (TGF-b) has been shown to have important regulatory functions in epithelial proliferation and di¡erentiation (Roberts, 1998; Ten Dijke et al, 2002) . Among the three TGF-b isoforms, TGF-b1 is known as the most prominent regulator. TGF-b1 inhibits epithelial cell growth through transcriptional repression of the growth promoting gene c-myc (Pietenpol et al, 1990) , and upregulates the cyclin-dependent kinase inhibitors p15 and p21 (Hannon and Beach, 1994; Datto et al, 1995) . This leaves the retinoblastoma protein in a hypo-phosphorylated state and thereby retains the cells in the G1 phase (Weinberg, 1995) . TGF-b1 can also induce apoptosis in keratinocytes (Min et al, 1999) , and a¡ect keratinocyte di¡erentiation by upregulating the expression of integrins and keratins (Mansbridge and Hanawalt, 1988; Jiang et al, 1995; Zambruno et al, 1995) . The crucial role of TGF-b1 for epithelial development is highlighted in studies on transgenic mice: the epidermis of TGF-b1-null mice displays marked hyperproliferation (Glick et al, 1993) , whereas mice with targeted overexpression of active TGF-b1 exhibit severely disrupted skin development, leading to neonatal death (Sellheyer et al, 1993) . TGF-b1 is predominantly secreted as a large latent protein complex, consisting of the mature (active) TGF-b1 homodimer, the latency-associated peptide (LAP), and the high molecular weight latent TGF-b binding protein (LTBP) (Wake¢eld et al, 1988; Miyazono et al, 1991) . Extracellularly, latent TGF-b1 is proteolytically cleaved with the release of active TGF-b1. On the target cell, active TGF-b1 binds to a hetero-tetrameric complex of two transmembrane signaling receptors: TGF-b type I (TbRI) and TGF-b type II (TbRII) receptors (Ebner et al, 1993) . TbRII phosphorylates TbRI upon binding of TGF-b1 (Wrana et al, 1994) and TbRI subsequently phosphorylates either of two intracellular protein homologs, Smad2 or Smad3 (Nakao et al, 1997b) . Phosphorylated Smad2 and Smad3 associate in the cytoplasm with Smad4 and the resulting complexes translocate to the nucleus, where they modulate transcription in collaboration with other coactivators and corepressors (Massague, 2000) . This signaling pathway, however, can be blocked by binding of Smad7 to the intracellular domain of the TbRI, which inhibits the phosphorylation of Smad2 and Smad3 (Nakao et al, 1997a) .
We have previously reported that ERY OL lesions show epithelial atrophy and hyperproliferation of basal keratinocytes compared with reticular OL and normal oral mucosa (NOM) epithelium (Karatsaidis et al, 2003) . From studies on transgenic mice with null expression of Smad3, or active TGF-b1 constitutively targeted to the keratin 10 promoter, or overexpression of Smad7 (Cui et al, 1995; Ashcroft et al, 1999; He et al, 2002) , it is known that interference with the TGF-b/Smad pathway can cause such changes. In this study, we show that this pathway is inhibited in ERY OL because, concomitantly with an increased activation of TGF-b1, there is an increased Smad7 expression and membrane translocation, and signi¢cantly reduced nuclear accumulation of Smad2, Smad3, and Smad4 in the epithelium of ERY OL. Parallel to the ¢ndings in transgenic mice, this thus may be the cause for the epithelial hyperproliferation in ERY OL.
MATERIALS AND METHODS
Specimens Biopsies were taken, after informed consent, from volunteers with ERY OL (n ¼ 12) or with NOM (n ¼ 11). No distinction was made between OLP and oral lichenoid reactions. Clinical diagnosis was made by an experienced clinician (TA), and pathologic diagnosis was con¢rmed on hematoxylin and eosin sections of the biopsies. The clinical and histopathologic criteria used were those described by Kramer et al (1978) . Buccal mucosal biopsies were taken from sites that typi¢ed the clinical diagnosis and character of the lesion. The volunteers were tested for oral Candida infection using Dentocult dip slides (Orion Diagnostica, Espoo, Finland) and the biopsies were examined by PAS staining. None of the patients included in this study showed Candida infection at the time of biopsy. Biopsies were snap-frozen on dry ice (À701C), oriented, embedded in OCT compound (Sakura Finetek, Tokyo, Japan), and stored at À801C. Biopsies for in situ hybridization were ¢xed in 4% bu¡er formaldehyde. Five micron thick sections were cut at À201C in a cryostat and slides were stored at À201C until used. The study was carried out according to the Helsinki Declaration's principles for biomedical research and approved by the Ethical Committee of Health, Oslo, Norway.
Immunohistology Antibodies against the following proteins were used in this study: the mature and active TGF-b1 (mouse IgG, 1.25 mg per ml, BioSource International, Camarillo, CA), LAP (TGF-b1) (goat IgG, 1.3 mg per ml, R&D, Oxfordshire, UK), LTBP-1 (rabbit IgG, 0.3 mg per ml, a kind gift from Dr C.-H. Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden), keratinocyte transglutaminase (mouse IgG, 0.45 mg per ml, Biomedical Technologies, Stoughton, MA). The following antibodies from Santa Cruz Biotechnology (Santa Cruz, CA) were used: TGF-bRI (rabbit IgG, 0.33 mg per ml), TGF-bRII (rabbit IgG, 0.25 mg per ml), phosphorylated Smad2/3 (rabbit IgG, 0.25 mg per ml), Smad4 (mouse IgG, 2 mg per ml), Smad7 (goat IgG, 4 mg per ml), plasminogen activator inhibitor 1 (PAI-1) (mouse IgG, 1 mg per ml).
Single stainings were performed after ¢xation of cryosections in 4% paraformaldehyde for 20 min, followed by 2 Â 5 min washes in phosphate-bu¡ered saline (PBS) and preincubation with 0.3% H 2 O 2 for 30 min. Sections were rewashed and incubated in 5% of appropriate normal serum for 30 min (the species of the normal serum used was equivalent to the species of the secondary antibody used; see below). Primary antibodies were diluted in PBS with 1% bovine serum albumin, applied on the sections, and incubated overnight at 41C. Subsequently, the sections were washed in PBS and incubated 30 min with the appropriate secondary biotinylated antibody preparation (horse antimouse IgG, goat antirabbit IgG, or rabbit antigoat IgG, all diluted 1:200 and all from Vector Laboratories, Burlingame, CA). After washing in PBS, sections were incubated with avidinÀbiotin complex conjugated with horseradish peroxidase (Vector Laboratories) for 30 min, washed, and ¢nally developed with 3,3 0 -diaminobenzidine as substrate (Sigma-Aldrich, St Louis, MO).
In double stainings, the sections were ¢xed as above, washed in PBS, and incubated in 10% normal goat serum and 10% normal horse serum for 30 min. Primary antibodies for keratinocyte transglutaminase and LTBP-1 were diluted and incubated for 1 h. Sections were washed again in PBS followed by incubation of a secondary goat antirabbit biotinylated antibody preparation (1:200, Vector Laboratories) for 30 min. After washing, the sections were incubated in Cy3 -labeled streptavidin (1:1000, Amersham Pharmacia Biotech, Uppsala, Sweden) for 30 min. Sections were again washed, followed by sequential incubation with avidin (10 mg per ml) and biotin (1 mg per ml), both from Sigma-Aldrich, for 10 min each, and an incubation of a secondary horse antimouse biotinylated antibody preparation (1:200, Vector Laboratories) for 30 min. This was followed by incubation with Cy2-labeled streptavidin (1:1000, Amersham Pharmacia) for 30 min. Sections were ¢nally washed and counterstained with DAPI (Molecular Probes, Eugene, OR). Isotype-matched control antibodies showed no staining with the immunohistologic detection techniques used.
In situ hybridization After ¢xation in 4% bu¡ered formaldehyde solution for 24 h, biopsies were processed through graded alcohols, oriented, and embedded in para⁄n. Four micron thick para⁄n sections were cut and mounted on polylysine-coated glass slides. Prior to staining, sections were dewaxed and rehydrated according to standard procedures. Endogenous peroxidase activity was quenched with 3% H 2 O 2 in methanol. The sections were then rehydrated with distilled water and equilibrated in TE-bu¡er (10 mM TrisÀHCl, 1 mM ethylenediamine tetraacetic acid, pH 7.6). Permeabilization was performed with proteinase K (Sigma-Aldrich, 20 mg per ml in TE-bu¡er, 30 min, 371C). Proteolytic activity was stopped by incubation with glycine in PBS (2 mg per ml). Sections were post¢xed in 4% paraformaldehyde in PBS for 15 min. Acetylation was done with freshly prepared triethanolamine bu¡er (100 mM, pH 8) with 0.5% acetic anhydride (2 Â 5 min). Equilibration and prehybridization were carried out with 5 Â sodium citrate/chloride bu¡er (SSC) (10 min, room temperature) and hybridization bu¡er (Dako; 2 h, 52 1C), (DAKO, Glostrup, Denmark) respectively. For hybridization, sections were incubated for 18 h at 52 1C with biotinylated antisense or sense probe (GreenStar Biotin 10 oligonucleotide probe; antisense, 48 bp hybridizing to nucleotides 440^487 in the coding sequence of human Smad7; GeneDetect, Auckland, New Zealand) diluted in hybridization bu¡er (1 mg per ml). Stringency washes were 2 Â SSC (1 h, 521C), 2 Â SSC diluted with 50% formamide (20 min, 521C), 0.1 ÂSSC (20 min, 521C). Blocking was done with Tris-bu¡ered saline (TBS; 0.1 M TrisÀHCl, pH 7.5, 0.15 M NaCl) with 1% casein (TBS-C). Further incubations and washings were then peroxidase-conjugated rabbit antibiotin antibodies (Dako P5106, 1:100 in TBS-C, 30 min), washing with TBS with 0.05% Tween 20 (TBS-T), biotinyl-tyramide (Dako GenPoint kit K0620; 8 min), washing with PBS-T, alkaline phosphatase-conjugated rabbit antibiotin antibodies (Dako D5107; 1:75 in TBS-C, 30 min). The sections were ¢nally developed with BCIP/NBT substrate (20 min) and counterstained with Nuclear Fast Red. All aqueous solutions for in situ hybridizations were prepared with DEPC-distilled water.
Cell countings Images of sections were captured with a digital camera using objectives with 20Â , 40Â , 60Â , or 100Â magni¢cation and monitored on a 17-inch computer screen by means of an imaging software program (Soft Imaging System, Mˇnster, Germany). Cell countings were made using objectives with 20Â magni¢cation. For ERY OL specimens, the ¢eld chosen for counting was located over the in£ammatory cell in¢ltrate. Total numbers of keratinocytes and numbers of immunohistochemically stained nuclei were counted in the entire part of the epithelium visible on the computer screen.
Statistics t tests were used to compare di¡erences between groups. Di¡erences were considered to be statistically signi¢cant at po0.001.
RESULTS
An overview of the stainings is presented in Table I .
In NOM, basal, spinous, and granular cell layers showed perinuclear, nuclear, and cytoplasmic staining for LAP-TGF-b1 that gradually decreased in intensity from the spinous to the outer epithelial surface (Fig 1a) . Cytoplasmic staining for LTBP-1 was seen in all epithelial cell layers in NOM, and this was strongest in spinous, granular, and super¢cial cell areas (Fig 1c) . Speckled staining for active TGF-b1 was observed in upper spinous and granular layers (Fig 1e with enlargement, showing arrow-marked spots). Strong con£uent staining for active TGF-b1 was seen in the outermost super¢cial epithelial cell layer in NOM (Fig 1e) . TbRI and TbRII expression was present as a nuclear, a cell membrane, and a cytoplasmic staining in all NOM epithelial cell layers (Fig 1g, i) . In NOM epithelium, the staining was most intense in basal cell layers for both TbRI and TbRII. The majority of the cells throughout the epithelium showed nuclear and cytoplasmic staining for both phosphorylated Smad2/3 and Smad4 (Fig 1k, m, respectively) . NOM epithelium showed areas with patched weak or no cytoplasmic staining for Smad7 (Fig 1o with  enlargement) . In situ hybridization showed only very weak and scattered nuclear and perinuclear Smad7 mRNA in basal keratinocytes of NOM (Fig 1q; antisense) . Control hybridization (sense) did not show any staining (Fig 1r) .
In ERY OL, basal and lower spinous layers showed cytoplasmic staining for LAP-TGF-b1, which was especially intense around cell nuclei (Fig 1b with enlargement) . Typically, a bandlike area with only scattered or absent LAP-TGF-b1 staining was observed in the uppermost spinous and granular cell layers (Fig 1b with enlargement) . There was strong cytoplasmic staining for LTBP-1 in basal and lower spinous cell layers (Fig 1d) . In upper spinous and granular epithelial layers, this staining had a marked pericellular and intercellular location (Fig 1d with enlargement) . Active TGF-b1 consistently showed a clear cell membrane/pericellular staining in the granular and upper spinous epithelial layers, but not in the basal cell layers in ERY OL epithelium (Fig 1f with enlargement) . This band of active TGFb1 staining was complementary to the cell layers that displayed decreased LAP-TGF-b1 staining (compare Fig 1b, f with respective enlargements). The reduced stores of LAP-TGF-b1 may therefore be a direct result of depletion of latent TGF-b1 in these layers as a consequence of increased activation. Cell membrane, cytoplasmic, and intense perinuclear staining for TbRI and TbRII was seen (Fig 1h, j, respectively) . This staining was strongly reduced or absent in granular and in upper parts of the spinous epithelial cell layers, often in a band-like pattern, similar to that described above for LAP-TGF-b1. Phosphorylated Smad2/3 (Fig 1l with enlargement) and Smad4 (Fig 1n with enlargement) stainings revealed signi¢cantly reduced numbers of cells with nuclear and/or cytoplasmic staining among keratinocytes in all epithelial layers in OL compared with epithelial cells in NOM ( Table II , pp0.001, t test). The Smad7 staining pattern in ERY OL was profoundly altered compared with NOM (Fig 1p with  enlargement) . In contrast to the nearly absent Smad7 expression in NOM, basal and suprabasal cell layers in ERY OL showed strong cytoplasmic Smad7 staining. In spinous and granular layers, the Smad7 staining was particularly localized to the cell membrane. Almost all basal keratinocytes showed strong nuclear and perinuclear expression of Smad7 mRNA in ERY OL epithelium (Fig 1; antisense) . Control hybridization (sense) did not reveal any staining (Fig 1t) .
LTBP-1 has been demonstrated to be targeted to elements of the extracellular matrix through cross-linking by the enzyme transglutaminase (Nunes et al, 1997; Verderio et al, 1999) . Double staining for LTBP-1 and keratinocyte transglutaminase in NOM epithelium showed that LTBP-1 was localized preferentially in the cytoplasm and keratinocyte transglutaminase in cell membrane/pericellular epithelial areas (Fig 1u) . In contrast, double staining for LTBP-1 and keratinocyte transglutaminase in ERY epithelium showed a cell membrane/pericellular codistribution of these molecules in spinous and granular cell layers (Fig 1  (v1^v3) ).
Finally, we carried out staining for PAI-1, which is upregulated by TGF-b through Smad (Dennler et al, 1998) . NOM epithelium showed ample cytoplasmic and pericellular staining in spinous and granular cell layers (Fig 1w) . In contrast, there was very little staining for PAI-1 in ERY OL epithelium, and this was restricted to only scattered epithelial cells (Fig 1x) .
In sum, TGF-b1 was strongly activated in parts of the ERY OL epithelium, but the signal transduction through Smad appeared to be blocked by Smad7. This was accompanied by a concomitant decreased expression of PAI-1 in ERY OL epithelium.
DISCUSSION
The integrity of normal strati¢ed epithelium is maintained by a balance between proliferation of basal epithelial cells and continuous shedding of terminally di¡erentiated epithelial cells (Jetten and Harvat, 1997; Gandarillas, 2000) . Epithelial and stromal cells produce an array of cytokines and growth factors that bind to corresponding receptors on epithelial cells, which upon activation can have a wide variety of antagonistic and synergistic e¡ects on keratinocyte proliferation and di¡erentiation (Dotto, 1999; Freedberg et al, 2001) . In this in situ study, we examined the activation status of TGF-b1 and its intracellular signaling pathway mediated through Smad molecules.
In NOM, we disclosed evidence for active nuclear Smad signaling in the epithelium: numerous Smad4 and phosphorylated Smad2/3 positive nuclei were present, with only sparse signs of 
0, no staining; 7, very weak staining; þ, weak staining; þ þ, moderate staining; þ þ þ, strong staining. Smad7 expression. This accords with observations in normal skin epidermis, where Smad2, Smad3, and Smad4 nuclear staining also was seen in the epidermal basal, spinous, and granular keratinocytes (He et al, 2001) . The Smad activation indicates that this, by inference, has a physiologic regulatory function of keratinocyte proliferation and di¡erentiation. Several factors can trigger such Smad signaling.
(1) Active TGF-b1 could have been a likely activator, but this was only seen at low levels in the uppermost spinous and granular epithelial cell layers and not among basal and suprabasal keratinocytes where it should have been to exert its growth inhibitory function. This accords with observations from normal epidermis where it is also absent (Kane et al, 1991) .
(2) Growth factors that in£uence epithelial proliferation and differentiation by signaling through MAPK (e.g., epidermal growth factor and hepatocyte growth factor) can mediate activation and nuclear translocation of Smad2 (de Caestecker et al, 1998) . This type of cross-talk between Smad and MAPK pathways may also exist in NOM epithelium. (3) Signaling could be induced by TGF-b2 and/or TGF-b3 (Paterson et al, 2001 ). This is not likely because TGF-b2 and TGF-b3 are only expressed in the upper spinous and the granular layers in NOM epithelium (own observations, data not shown) where any action on growth regulation of basal cells is unlikely. (4) Signaling could occur through activin, as activin can regulate keratinocyte di¡erentiation (Beer et al, 2000) and mediate downstream Smad2/3 -induced transcription (Lebrun et al, 1999) . In OL, the normal epithelial structure is severely disrupted, with changes such as hyperkeratosis, atrophy, and degeneration of basal cells (Andreasen, 1968; Kramer et al, 1978) . In addition, the epithelium shows an abnormally high proliferation rate in the basal cell layer in the ERY form of the disease (Karatsaidis et al, 2003) . Such changes could be caused by inhibition of the growth regulatory activity of TGF-b1. In this study we therefore examined TGF-b1 signaling in ERY OL at the level of production and activation of the ligand, of TbRI and TbRII expression, and of Smad signal transduction, and we conclude the following.
(1) Production and activation of TGF-b1 are not de¢cient in ERY OL because there was ample staining for latent TGF-b1 (as shown by the presence of LAP-TGF-b1) and a strong staining for active TGF-b1 in the upper parts of the spinous layer and in the granular cell layer. The activation markedly exceeded the levels seen in NOM, but TGF-b1 activation was con¢ned to the more super¢cial di¡erentiating cell layers and was not seen among basal cells where it could have had an antiproliferative e¡ect. (2) TGF-b signaling is probably not obstructed by de¢-cient expression of TbRI and TbRII because the receptors were normally expressed in basal and spinous layers of the ERY OL epithelium. Incidentally, the upper spinous and granular layers showed a reduced TbRI/TbRII expression. This could be a desensitizing/downregulating response to the increased TGF-b1 activityöa mechanism that has been documented in vitro (Prime et al, 1994; Zwaagstra et al, 1999) . It has also recently been shown that Smad7 can be involved in degradation of TGF-b receptors at the protein level (Kavsak et al, 2000) . As Smad7 was located at the level of the cell membrane in the uppermost spinous and granular layers in ERY OL, this also could contribute to the reduced expression of TbRI and TbRII at this location. (3) There appears to be blockage of the TGF-b1 signal through Smad2 and Smad3 in ERY OL, because there were signi¢cantly decreased numbers of cells with nuclear accumulation of the signaling molecules Smad2, Smad3, and Smad4 in all epithelial cell layers, concomitant with a marked cell membrane localization of the inhibitory signaling molecule Smad7. Moreover, Smad7 transcription was shown to be signi¢cantly upregulated in basal keratinocytes of ERY OL compared with NOM. Blockage of Smad2 and Smad3 phosphorylation by Smad7 may thus be the cause for the increased proliferation rate in ERY OL epithelium. This notion is strongly supported by studies in transgenic mice that show that both Smad3-null mice and mice with overexpression of Smad7 display increased keratinocyte proliferation (Ashcroft et al, 1999; He et al, 2002) . Moreover, transgenic mice with constitutive active TGF-b1 coupled to the keratin 10 promoter (which targets TGFb1 to suprabasal epithelial cell layers) also show epidermal hyperproliferation, suprabasal TGF-b1 activation, and epithelial atrophy (Cui et al, 1995) . The ¢ndings in the latter model strongly resemble our observations in ERY OL epithelium. It is likely that a signaling blockage by Smad7 was in part responsible for the (then unexpected) increased epithelial proliferation seen in the keratin-10-TGF-b1 transgenic mice.
The site (i.e., the epithelial layers) where TGF-b1 exerts its activity is known to be crucial for the morphology of the epithelium. TGF-b1 activation within the basal cell layer in£icts major damage to the epithelium: e.g., transgenic mice with constitutive expression of active TGF-b1 targeted to basal keratinocytes do not survive because of a total inhibition of basal cell proliferation (Sellheyer et al, 1993) . Other transgenic strains, where latent TGFb1 expression was coupled to keratin 14 promoter (which is conditionally activated in basal keratinocytes), showed marked defects in re-epithelialization during wound healing (Yang et al, 2001) . This may be the reason whyTGF-b1 during normal wound healing is activated in a con¢ned compartment of the more super¢cial epithelial cell layers, at a distance from the proliferative basal cells (Kane et al, 1991) . The observed restricted activation of TGF-b1 in ERY OL epithelium resembles this pattern. Our stainings for LTBP-1 and keratinocyte transglutaminase expression might give a clue to why this activation shows this con¢ne-ment. In connective tissue, LTBP-1 has a function in targeting latent TGF-b to the extracellular matrix and transglutaminase contributes to this process because it cross-links LTBP-1 to extracellular matrix elements (Nunes et al, 1997) . Transglutaminase is not expressed in basal keratinocytes in oral mucosa (Ta et al, 1990 ;present observations) and if transglutaminase and LTBP-1 have a similar TGF-b targeting function in epithelium as in connective tissue, this might explain the con¢nement of the TGF-b1 activation. Therefore, as long as the TGF-b1 activity remains compartmentalized as in the present ERY OL biopsies, the lesion could be regarded as a wound that is trying to heal normally but is kept in an unresolved state by the chronic in£ammatory in¢l-trate (see below). If TGF-b1, however, would become very strongly activated and a¡ect the basal cell layers, epithelial proliferation could become so severely inhibited that the lesion then perhaps might turn into its ulcerative form.
The epithelial di¡erentiation pattern and cell death mode are disturbed in ERY OL (Karatsaidis et al, 2003) , which is the underlying cause for the morpho-pathologic changes typical for the disease. Besides inhibiting epithelial growth, TGF-b1 can a¡ect epithelial di¡erentiation by regulating, for example, keratin and integrin expression and apoptosis (Mansbridge and Hanawalt, 1988; Jiang et al, 1995; Zambruno et al, 1995; Min et al, 1999) . Altered epidermal di¡erentiation resembling that in OL can be seen in transgenic mice in which the TGF-b signaling pathway was manipulated; mice with overexpressed epidermal Smad7 show acanthosis and hyperkeratosis (He et al, 2002) and keratin-10-TGF-b1 transgenic mice in which the epidermis was treated with 12-O-tetradecanoylphorbol-13 -acetate (a hyperplasia inducing agent) acquire pronounced epidermal atrophy (Cui et al, 1995) . It is therefore possible that the detected inhibition of the TGF-b signaling pathway plays a role in the epithelial atrophy in ERY OL (Karatsaidis et al, 2003) .
Based on prospective follow-up studies of large groups of OLP patients, it has been suggested that OLP can be a premalignant condition because a small fraction of the initial lesions diagnosed as plaque or ERY OLP over time developed into cancer (Holmstrup et al, 1988) . Loss of Smad and TGF-b receptor signaling has been observed in cancer cells, and this is associated with decreased growth inhibitory control of TGF-b (Pasche, 2001) . Even though the TGF-b/Smad signaling blockade was not complete in ERY OL, alterations in this growth inhibitory pathway might perhaps, in concert with other predisposing factors, play a role in dysplastic transformation of ERY OL. (a, c, e, g, i, k, m, o, u, w) and patients with OL (b, d, f, h, j, l, n, p, v, x) . After immunohistochemical staining the labeled molecules are seen in brown (counterstain with hematoxylin) and for immuno£uorescence (u, v) the speci¢c molecules are displayed in red and green (overlapping red and green appear yellow; blue nuclear stain with DAPI). Antibodies used were against (a), (b) LAP-TGF-b1; (c), (d ) LTBP-1; (e), (f ) active TGF-b1 (arrows in (e) indicate spotted staining); (g), (h) TbRI; (i), (j ) TbRII; (k), (l ) phoshorylated Smad2/3; (m), (n) Smad4; (o), (p) Smad7; (q), (r) LTPB-1 in red, keratinocyte transglutaminase in green (position of the basement membrane indicated with white broken lines); (w), (x) mature PAI-1; in situ hybridization for Smad7 (q, r, s, t; labeled molecules are in blue; counterstain with red). Low magni¢cation pictures (lettered a to x, except for q, r, s, t) were obtained with a 20Â objective (scale bar: 100 mm). High magni¢cation pictures (without lettering) were taken with a 60Â objective, except for enlargements (e) and (k), which were taken with 100Â and 40Â objectives, respectively. Micrographs of in situ hybridization (q, r, s, t) were obtained with a 40Â objective. Frames of high magni¢cation are connected to their respective low magni¢cation areas with arrows. Scale bar for £uorescence ¢gures (u, v) is 10 mm. Upregulation of the expression of Smad7 can be caused by pro-in£ammatory cytokines like interferon-g and tumor necrosis factor a (Ulloa et al, 1999; Bitzer et al, 2000) . These are believed to be central regulatory cytokines in OL, and are synthesized and secreted by activated keratinocytes and in£ammatory cells in the subepithelial in¢ltrate (Yamamoto and Osaki, 1995) . Typically, Smad7 mRNA was observed in the basal keratinocyte layer in ERY OL. The increased basal cell proliferation in ERY OL epithelium (Karatsaidis et al, 2003) can thus be due to inhibition of TGF-b/Smad signaling by Smad7, induced by interferon-g and tumor necrosis factor a.
TGF-b is a strong upregulator of the transcription of PAI-1 in human keratinocytes (Keski-Oja and Koli, 1992) . Elements in the PAI-1 promoter that are binding sites for the Smad3ÀSmad4 heterodimer have indeed been identi¢ed (Dennler et al, 1998) . PAI-1 expression in ERY OL epithelium was strongly reduced, which indicates a blockage at the functional level of the TGF-b/Smad signaling pathway.
In sum, these results indicate that there is a functional blockage of the TGF-b signaling pathway by increased Smad7 expression and translocation in ERY OL. This may explain the increased hyperproliferation and the disturbed terminal di¡erentiation of keratinocytes observed in this disease.
